Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02077504 : Glial Tumors Electromagnetic Signature Study by MagnetoEncephaloGraphy (MEG) "CONDUCTOME"
PhasePhase 1
AgesMin: 18 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- more or equal than 18 years old

- patient affiliated to social security or similarly regime

- informed consent form signed

- supra-tentorial primitive cerebral tumor

Exclusion Criteria:

- Pregnant women and lactating mothers

- Ward of court or under guardianship

- Adult unable to express their consent

- Person deprived of freedom by judicial or administrative decision

- Person hospitalized without their consent

- Person under legal protection

- Magnetic Resonance Imaging (MRI) contraindication (implanted material non
MRI-compatible, ferro-magnetic foreign body, claustrophobia)

- Patients needed emergency medical care for other pathology

- severely altered general health (Performance Status 3 or 4)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02077504      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740